Metformin has been one of the most familiar names in the treatment of type 2 diabetes, primarily recognized for its ability to help control elevated blood glucose. But new research is encouraging scientists to look beyond the liver and digestive system to understand exactly how this long-established medicine works. A study published in Science Advances in 2025 suggests that metformin may also influence blood-sugar regulation through a pathway in the brain, adding an unexpected dimension to a medicine that has been used clinically for more than 60 years. The finding does not mean metformin is a new brain medicine, nor does it show that patients are being harmed. Instead, it highlights how much scientists may still have to learn about a drug that has been part of diabetes treatment for generations.
Metformin has a remarkably long scientific history. The compound was first synthesized in 1922, although its modern role in diabetes treatment emerged much later. Over the decades, it became a cornerstone of type 2 diabetes management because of its glucose-lowering effects, relatively long clinical history, affordability, and established place in treatment. Traditionally, researchers have understood one of its major actions as reducing the amount of glucose released by the liver while helping the body use insulin more effectively. The new findings suggest that explanation may not tell the whole story, as per Science Alert report.
